Description
                        
                          Foreword by D.A. Wallach: It is time for healthcare to embrace patients  Preface  Introduction: The Context  Part I: What Are Digital Therapeutics?  1. Digital Health Solutions Versus Digital Therapeutics  Part II: The Right Tool for The Right Problem  1. Addressing Unmet Stakeholder Needs  2. Addressing Unmet Clinical Needs  3. Ensuring Business Viability Early  4. Test, Learn, and Pivot  Part III: From Pilot to Production  5. Data Sourcing and Management  6. Gathering Evidence: Novel Approaches to Clinical Validation  7. Factors That Influence the Implementation of New Technologies  8. Recommendations for DTx Implementation  9. Supporting Adoption of DTx  Part IV: Paths to Commercialization  10. Channel Partnerships: The Ultimate Commercialization Strategy  11. The Price is Right:: Value in The Eye of The Beholder  Conclusion by Dr Eddie Martucci: The Future of DTx  Appendix  Bibliography  Acknowledgments  Index
                          
                            
                          
                        
                          Dean Ho (SINGAPORE) is the Provost's Chair Professor, the Director of the Institute for Digital Medicine and the N.1 Institute for Health, and the Head of the Department of Biomedical Engineering at the National University of Singapore. Yoann Sapanel (SINGAPORE) is the Head of Health Innovation at the Institute for Digital Medicine at the National University of Singapore. Agata Blasiak (SINGAPORE) is the Head of Digital Health Innovation at the Institute for Digital Medicine and the N.1 Institute for Health at the National University of Singapore.
                          
                            
                          
